Explore the evolving treatment strategies for metastatic clear cell renal cell carcinoma, highlighting innovative combination therapies and their efficacy.
Arnab Basu, MD, MPH, FACP
Arnab Basu, MD, MPH, FACP, is a medical oncologist specializing in the care of genitourinary cancers at Mayo Clinic.
Articles by Arnab Basu, MD, MPH, FACP
Arnab Basu, MD, MPH, FACP, discusses circulating tumor DNA (ctDNA) tests with high sensitivity and specificity.
Arnab Basu, MD, MPH, FACP, explains why sensitivity might be higher in urothelial cancer vs other genitourinary cancers.
Arnab Basu, MD, MPH, FACP, discusses his research on high sensitivity circulating tumor DNA assays in genitourinary malignancies.
Arnab Basu, MD, MPH, FACP, discusses molecular residual disease-guided adjuvant therapy in patients with renal cell carcinoma, highlighting the rationale and goals of the MRD gate RCC clinical trial.
Latest Updated Articles
Current Physician Treatment Preferences for Frontline Metastatic ccRCCPublished: August 25th 2025 | Updated: